Literature DB >> 14701748

Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A.

Heehyoung Lee1, Natalie Rezai-Zadeh, Edward Seto.   

Abstract

Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from lysine residues of histone and nonhistone proteins. Recent studies suggest that they are key regulators of many cellular events, including cell proliferation and cancer development. Human class I HDACs possess homology to the yeast RPD3 protein and include HDAC1, HDAC2, HDAC3, and HDAC8. While HDAC1, HDAC2, and HDAC3 have been characterized extensively, almost nothing is known about HDAC8. Here we report that HDAC8 is phosphorylated by cyclic AMP-dependent protein kinase A (PKA) in vitro and in vivo. The PKA phosphoacceptor site of HDAC8 is Ser(39), a nonconserved residue among class I HDACs. Mutation of Ser(39) to Ala enhances the deacetylase activity of HDAC8. In contrast, mutation of Ser(39) to Glu or induction of HDAC8 phosphorylation by forskolin, a potent activator of adenyl cyclase, decreases HDAC8's enzymatic activity. Remarkably, inhibition of HDAC8 activity by hyperphosphorylation leads to hyperacetylation of histones H3 and H4, suggesting that PKA-mediated phosphorylation of HDAC8 plays a central role in the overall acetylation status of histones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14701748      PMCID: PMC343812          DOI: 10.1128/MCB.24.2.765-773.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

Review 1.  Histone modifications in transcriptional regulation.

Authors:  Shelley L Berger
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

Review 2.  ATP-dependent nucleosome remodeling.

Authors:  Peter B Becker; Wolfram Hörz
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.

Authors:  E Hu; Z Chen; T Fredrickson; Y Zhu; R Kirkpatrick; G F Zhang; K Johanson; C M Sung; R Liu; J Winkler
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

Review 4.  Histone deacetylase inhibitors in cancer treatment.

Authors:  David M Vigushin; R Charles Coombes
Journal:  Anticancer Drugs       Date:  2002-01       Impact factor: 2.248

5.  Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions.

Authors:  Scott C Galasinski; Katheryn A Resing; James A Goodrich; Natalie G Ahn
Journal:  J Biol Chem       Date:  2002-03-27       Impact factor: 5.157

6.  Cloning and characterization of a novel human histone deacetylase, HDAC8.

Authors:  J J Buggy; M L Sideris; P Mak; D D Lorimer; B McIntosh; J M Clark
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

Review 7.  Histone deacetylases as therapeutic targets in hematologic malignancies.

Authors:  Ari Melnick; Jonathan D Licht
Journal:  Curr Opin Hematol       Date:  2002-07       Impact factor: 3.284

8.  Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1.

Authors:  J M Schmitt; P J Stork
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.

Authors:  C M Grozinger; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

10.  Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation.

Authors:  M K Pflum; J K Tong; W S Lane; S L Schreiber
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

View more
  54 in total

1.  Early life stress triggers sustained changes in histone deacetylase expression and histone H4 modifications that alter responsiveness to adolescent antidepressant treatment.

Authors:  Amir Levine; Trent R Worrell; Ross Zimnisky; Claudia Schmauss
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

2.  Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma.

Authors:  James S Wilmott; Andrew J Colebatch; Hojabr Kakavand; Ping Shang; Matteo S Carlino; John F Thompson; Georgina V Long; Richard A Scolyer; Peter Hersey
Journal:  Mod Pathol       Date:  2015-04-03       Impact factor: 7.842

3.  TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation.

Authors:  Hajime Ishinaga; Hirofumi Jono; Jae Hyang Lim; Soo-Mi Kweon; Haodong Xu; Un-Hwan Ha; Haidong Xu; Tomoaki Koga; Chen Yan; Xin-Hua Feng; Lin-Feng Chen; Jian-Dong Li
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

4.  Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension.

Authors:  ShengYu Mu; Tatsuo Shimosawa; Sayoko Ogura; Hong Wang; Yuzaburo Uetake; Fumiko Kawakami-Mori; Takeshi Marumo; Yutaka Yatomi; David S Geller; Hirotoshi Tanaka; Toshiro Fujita
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

Review 5.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

Review 6.  Histone acetylation in drug addiction.

Authors:  William Renthal; Eric J Nestler
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

7.  Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.

Authors:  Heehyoung Lee; Nilanjan Sengupta; Alejandro Villagra; Natalie Rezai-Zadeh; Edward Seto
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Heike Kostka; Graeme Eisenhofer; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

Review 9.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29

10.  TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms.

Authors:  Sarah A Benson; Joel D Ernst
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.